scholarly journals Health care utilisation of infants with chronic lung disease, related to hospitalisation for RSV infection

2001 ◽  
Vol 85 (6) ◽  
pp. 463-468 ◽  
Author(s):  
A Greenough
Keyword(s):  
Health Care ◽  
Lung Disease ◽  
Chronic Lung Disease ◽  
Health Care Utilisation ◽  
Care Utilisation ◽  
Rsv Infection

High versus restricted use of home oxygen therapy, health care utilisation and the cost of care in chronic lung disease infants

2004 ◽  
Vol 163 (6) ◽  
pp. 292-296 ◽  
Author(s):  
Anne Greenough ◽  
John Alexander ◽  
Sal Burgess ◽  
Phillip A. J. Chetcuti ◽  
Sarah Cox ◽  
...  
Keyword(s):  
Health Care ◽  
Lung Disease ◽  
Chronic Lung Disease ◽  
Oxygen Therapy ◽  
Health Care Utilisation ◽  
Cost Of Care ◽  
Home Oxygen Therapy ◽  
Care Utilisation ◽  
Restricted Use ◽  
The Cost

scholarly journals Corticosteroids in infant chronic lung disease

2004 ◽  
Vol 61 (3) ◽  
Author(s):  
C. May ◽  
A. Greenough
Keyword(s):  
Lung Disease ◽  
Chronic Lung Disease ◽  
Alternative Therapy ◽  
Neurodevelopmental Outcome ◽  
Health Care Utilisation ◽  
Respiratory Morbidity ◽  
Care Utilisation ◽  
Acute Side Effects ◽  
Postmenstrual Age

Chronic lung disease (CLD), defined as chronic oxygen dependency at 36 weeks postmenstrual age, is increasing and associated with chronic respiratory morbidity and high health care utilisation at follow up. Many strategies, tested in randomised trials, have failed to reduce CLD. In contrast, corticosteroids if given systemically within the first two weeks after birth reduce CLD and may also favourably influence survival. Unfortunately, systemically administered corticosteroids have many acute side-effects and adversely affect long term neurodevelopmental outcome. If given by inhalation, corticosteroids have fewer adverse effects, but are less efficacious. Further research is required to accurately identify infants at highest risk of developing CLD, the corticosteroid dosage associated with a positive risk: benefit ratio and preferably a safer and more effective alternative therapy.

Knowledge of a negative 13C-urea breath test reduces health care utilisation for dyspepsia in a population H pylori test and treat program

2000 ◽  
Vol 118 (4) ◽  
pp. A678
Author(s):  
Paul Moayyedi ◽  
Richard Feltbower ◽  
Sara Duffett ◽  
Will Crocombe ◽  
David Forman ◽  
...  
Keyword(s):  
Health Care ◽  
Breath Test ◽  
Health Care Utilisation ◽  
Urea Breath Test ◽  
Test And Treat ◽  
Care Utilisation ◽  
13C Urea Breath Test ◽  
H Pylori
Sign in / Sign up

Export Citation Format

Share Document